CIPLA
Quarterly Results Analysis [Sep2024]
CIPLA Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹7,051 Cr | ₹6,694 Cr | ₹6,163 Cr | ₹6,604 Cr | ₹6,678 Cr | ₹6,329 Cr | ₹5,739 Cr | ₹5,810 Cr |
Expenses | ₹5,165 Cr | ₹4,978 Cr | ₹4,847 Cr | ₹4,856 Cr | ₹4,944 Cr | ₹4,835 Cr | ₹4,566 Cr | ₹4,403 Cr |
Operating Income | ₹1,886 Cr | ₹1,716 Cr | ₹1,316 Cr | ₹1,748 Cr | ₹1,734 Cr | ₹1,494 Cr | ₹1,174 Cr | ₹1,408 Cr |
Other Income | ₹191 Cr | ₹160 Cr | ₹249 Cr | ₹185 Cr | ₹176 Cr | ₹136 Cr | ₹135 Cr | ₹114 Cr |
Interest | ₹15 Cr | ₹18 Cr | ₹18 Cr | ₹30 Cr | ₹26 Cr | ₹16 Cr | ₹34 Cr | ₹32 Cr |
Depreciation | ₹272 Cr | ₹247 Cr | ₹288 Cr | ₹233 Cr | ₹290 Cr | ₹239 Cr | ₹346 Cr | ₹272 Cr |
Profit Before Tax | ₹1,789 Cr | ₹1,611 Cr | ₹1,259 Cr | ₹1,474 Cr | ₹1,594 Cr | ₹1,375 Cr | ₹745 Cr | ₹1,218 Cr |
Profit After Tax | ₹1,306 Cr | ₹1,176 Cr | ₹934 Cr | ₹1,069 Cr | ₹1,156 Cr | ₹997 Cr | ₹523 Cr | ₹808 Cr |
EPS | ₹16.13 | ₹14.58 | ₹11.63 | ₹13.08 | ₹14.01 | ₹12.33 | ₹6.51 | ₹9.92 |
Industry Peers & Returns | 1W | 1M | 1Y |
CIPLA | 0.5% | -1.7% | 29.4% |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% | -4% | 52.9% |
DR REDDYS LABORATORIES | 1.1% | -2.6% | 19.2% |
ZYDUS LIFESCIENCES | -3.6% | -8.4% | 62.9% |
DIVIS LABORATORIES | 0.7% | -0% | 70.9% |
MANKIND PHARMA | -2.8% | -0.7% | 52% |
TORRENT PHARMACEUTICALS | -0.1% | -7.2% | 58.1% |
LUPIN | -3.9% | -2.4% | 77.5% |
AUROBINDO PHARMA | -5.7% | -9.4% | 49.7% |
CIPLA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.33 % |
Y-o-Y | 5.58 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹7,051 Cr | 5.33 | |
Jun2024 | ₹6,694 Cr | 8.61 | |
Mar2024 | ₹6,163 Cr | -6.67 | |
Dec2023 | ₹6,604 Cr | -1.11 | |
Sep2023 | ₹6,678 Cr | 5.52 | |
Jun2023 | ₹6,329 Cr | 10.27 | |
Mar2023 | ₹5,739 Cr | -1.22 | |
Dec2022 | ₹5,810 Cr | - |
CIPLA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.90 % |
Y-o-Y | 8.76 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹1,886 Cr | 9.90 | |
Jun2024 | ₹1,716 Cr | 30.39 | |
Mar2024 | ₹1,316 Cr | -24.70 | |
Dec2023 | ₹1,748 Cr | 0.79 | |
Sep2023 | ₹1,734 Cr | 16.05 | |
Jun2023 | ₹1,494 Cr | 27.28 | |
Mar2023 | ₹1,174 Cr | -16.61 | |
Dec2022 | ₹1,408 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 4.33 % |
Y-o-Y | 3.00 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 26.74% | 4.33 | |
Jun2024 | 25.63% | 20.05 | |
Mar2024 | 21.35% | -19.31 | |
Dec2023 | 26.46% | 1.93 | |
Sep2023 | 25.96% | 10.00 | |
Jun2023 | 23.6% | 15.40 | |
Mar2023 | 20.45% | -15.60 | |
Dec2022 | 24.23% | - |
CIPLA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 11.03 % |
Y-o-Y | 13.00 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹1,306 Cr | 11.03 | |
Jun2024 | ₹1,176 Cr | 25.89 | |
Mar2024 | ₹934 Cr | -12.55 | |
Dec2023 | ₹1,069 Cr | -7.55 | |
Sep2023 | ₹1,156 Cr | 15.98 | |
Jun2023 | ₹997 Cr | 90.51 | |
Mar2023 | ₹523 Cr | -35.26 | |
Dec2022 | ₹808 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 5.41 % |
Y-o-Y | 6.99 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 18.52 % | 5.41 | |
Jun2024 | 17.57 % | 15.90 | |
Mar2024 | 15.16 % | -6.30 | |
Dec2023 | 16.18 % | -6.53 | |
Sep2023 | 17.31 % | 9.90 | |
Jun2023 | 15.75 % | 72.89 | |
Mar2023 | 9.11 % | -34.51 | |
Dec2022 | 13.91 % | - |
CIPLA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 10.63 % |
Y-o-Y | 15.13 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹16.13 | 10.63 | |
Jun2024 | ₹14.58 | 25.37 | |
Mar2024 | ₹11.63 | -11.09 | |
Dec2023 | ₹13.08 | -6.64 | |
Sep2023 | ₹14.01 | 13.63 | |
Jun2023 | ₹12.33 | 89.40 | |
Mar2023 | ₹6.51 | -34.38 | |
Dec2022 | ₹9.92 | - |
You may also like the below Video Courses